Prophylactic agent for brain atrophy, method for preventing brain atrophy, culture, use of culture, food or beverage, food for preventing brain atrophy, supplement for preventing brain atrophy, and medicine for preventing brain atrophy
Administering Bifidobacterium breve MCC1274 culture orally addresses brain atrophy and cognitive decline by reducing atrophy and improving cognitive functions in individuals at risk or with mild cognitive impairment.
AU2022371908B2Pending Publication Date: 2026-08-27MORINAGA MILK IND CO LTD
2 Cites 0 Cited by
Patent Information
- Application Number
- AU2022371908
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-10-22
- Filing Date
- 2022-10-21
- Publication Date
- 2026-08-27
AI Technical Summary
Technical Problem
There is a need for effective methods and agents to suppress brain atrophy, particularly in healthy individuals, those with mild cognitive impairment, and those at risk of neurodegenerative diseases, as brain atrophy can lead to cognitive decline and conditions like Alzheimer's disease.
Method used
A culture containing Bifidobacterium breve MCC1274 (FERM BP-11175) is administered orally in specific doses to individuals at risk of brain atrophy or diagnosed with cognitive decline to suppress brain atrophy and improve cognitive functions.
Benefits of technology
The culture effectively suppresses brain atrophy and improves cognitive functions by reducing atrophy in key brain areas and enhancing orientation, as shown by MRI and cognitive assessment tools.
✦ Generated by Eureka AI based on patent content.
Abstract
This prophylactic agent for brain atrophy is intended to be administered to any one subject selected from a normal person, a person who is diagnosed as having mild cognitive impairment, a person who is examined to be deteriorated in cognitive function, a subject who is at a risk of being affected by a neurodegenerative disease, and contains a culture containing Bifidobacterium breve MCC1274 (FERM BP-11175) as an active ingredient.
Need to check novelty before this filing date? Find Prior Art